FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

416468004: Drotrecogin alfa activated (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2005. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2546678017 Drotrecogin alfa activated (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2548981015 Drotrecogin alfa activated en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
807721000172118 drotrécogine alpha, activé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Drotrecogin alfa activated (substance) Is a Protein C (activated) false Inferred relationship Some
Drotrecogin alfa activated (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Coagulation factor inhibitor (disposition) false Inferred relationship Some
Drotrecogin alfa activated (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Protease inhibitor protein (disposition) true Inferred relationship Some
Drotrecogin alfa activated (substance) Is a Recombinant human activated protein c (substance) true Inferred relationship Some
Drotrecogin alfa activated (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Activated coagulation factor (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing drotrecogin alfa (activated) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Drotrecogin alfa activated (substance) Inferred relationship Some
Drotrecogin alfa (activated) 5mg powder for infusion solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Drotrecogin alfa activated (substance) Inferred relationship Some
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Drotrecogin alfa activated (substance) Inferred relationship Some

This concept is not in any reference sets

Back to Start